Susquehanna International Group’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.6M | Buy |
412,707
+362,433
| +721% | +$30.4M | ﹤0.01% | 266 |
|
|
2025
Q1 | $3.59M | Buy |
50,274
+23,742
| +89% | +$1.7M | ﹤0.01% | 1570 |
|
|
2024
Q4 | $1.19M | Buy |
26,532
+14,824
| +127% | +$666K | ﹤0.01% | 2733 |
|
|
2024
Q3 | $591K | Sell |
11,708
-27,476
| -70% | -$1.39M | ﹤0.01% | 3421 |
|
|
2024
Q2 | $1.6M | Buy |
39,184
+30,162
| +334% | +$1.23M | ﹤0.01% | 1997 |
|
|
2024
Q1 | $386K | Sell |
9,022
-12,598
| -58% | -$539K | ﹤0.01% | 3857 |
|
|
2023
Q4 | $870K | Buy |
+21,620
| New | +$870K | ﹤0.01% | 3058 |
|
|
2023
Q1 | – | Sell |
-11,545
| Closed | -$22.9K | – | 6642 |
|
|
2022
Q4 | $22.9K | Buy |
+11,545
| New | +$22.9K | ﹤0.01% | 5334 |
|
|
2022
Q3 | – | Sell |
-1,123
| Closed | -$3K | – | 6827 |
|
|
2022
Q2 | $3K | Buy |
1,123
+145
| +15% | +$387 | ﹤0.01% | 5631 |
|
|
2022
Q1 | $3K | Sell |
978
-8,138
| -89% | -$25K | ﹤0.01% | 5647 |
|
|
2021
Q4 | $56K | Buy |
9,116
+2,056
| +29% | +$12.6K | ﹤0.01% | 5442 |
|
|
2021
Q3 | $97K | Sell |
7,060
-472
| -6% | -$6.49K | ﹤0.01% | 4988 |
|
|
2021
Q2 | $129K | Buy |
7,532
+2,452
| +48% | +$42K | ﹤0.01% | 5005 |
|
|
2021
Q1 | $96K | Buy |
5,080
+2,498
| +97% | +$47.2K | ﹤0.01% | 4990 |
|
|
2020
Q4 | $75K | Buy |
2,582
+105
| +4% | +$3.05K | ﹤0.01% | 4554 |
|
|
2020
Q3 | $93K | Buy |
+2,477
| New | +$93K | ﹤0.01% | 4108 |
|
|
2020
Q2 | – | Sell |
-5,158
| Closed | -$184K | – | 4853 |
|
|
2020
Q1 | $184K | Buy |
5,158
+4,078
| +378% | +$145K | ﹤0.01% | 3830 |
|
|
2019
Q4 | $48K | Buy |
+1,080
| New | +$48K | ﹤0.01% | 3785 |
|
|
2018
Q1 | – | Sell |
-1,080
| Closed | -$29K | – | 4404 |
|
|
2017
Q4 | $29K | Buy |
+1,080
| New | +$29K | ﹤0.01% | 3503 |
|
|
2017
Q2 | – | Sell |
-396
| Closed | -$20K | – | 4272 |
|
|
2017
Q1 | $20K | Buy |
+396
| New | +$20K | ﹤0.01% | 3120 |
|